LALPATHLAB — Dr. Lal PathLabs Balance Sheet
0.000.00%
- IN₹249.17bn
- IN₹242.09bn
- IN₹22.27bn
- 100
- 7
- 86
- 75
Annual balance sheet for Dr. Lal PathLabs, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | R2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 7,317 | 9,840 | 6,817 | 8,143 | 9,426 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 742 | 927 | 1,083 | 953 | 1,119 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 8,926 | 11,452 | 8,752 | 9,731 | 11,267 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 3,021 | 3,120 | 4,298 | 4,040 | 3,470 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 13,743 | 16,613 | 23,468 | 23,856 | 24,560 |
Accounts Payable | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 2,273 | 2,743 | 5,000 | 4,698 | 4,652 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 3,415 | 4,163 | 8,451 | 7,193 | 6,067 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | 10,328 | 12,451 | 15,016 | 16,663 | 18,493 |
Total Liabilities & Shareholders' Equity | 13,743 | 16,613 | 23,468 | 23,856 | 24,560 |
Total Common Shares Outstanding |